尿路上皮がん治療の世界市場（～2026年）

• 英文タイトル：Global Urothelial Carcinoma Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04956
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は尿路上皮がん治療のグローバル市場について調査・分析したレポートです。種類別（免疫療法、放射線療法、化学療法）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別尿路上皮がん治療の競争状況、市場シェア
・世界の尿路上皮がん治療市場：種類別市場規模 2015年-2020年（免疫療法、放射線療法、化学療法）
・世界の尿路上皮がん治療市場：種類別市場規模予測 2021年-2026年（免疫療法、放射線療法、化学療法）
・世界の尿路上皮がん治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他）
・世界の尿路上皮がん治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他）
・北米の尿路上皮がん治療市場分析：米国、カナダ
・ヨーロッパの尿路上皮がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの尿路上皮がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の尿路上皮がん治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの尿路上皮がん治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：GlaxoSmithKline、Novartis、Merck、Sanofi、Bristol-Myers Squibb、Genentech、Eisai、Dendreon
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar cancer in other parts of the urinary tract.
Americas is likely to dominate the urothelial carcinoma treatment market owing to the increasing prevalence of bladder cancer, increasing investment in research and development of new bladder cancer treatment.

Market Analysis and Insights: Global Urothelial Carcinoma Treatment Market
The global Urothelial Carcinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Urothelial Carcinoma Treatment Scope and Market Size
Urothelial Carcinoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Urothelial Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GlaxoSmithKline
Novartis
Merck
Sanofi
Bristol-Myers Squibb
Genentech
Eisai
Dendreon

Market segment by Type, the product can be split into
Immunotherapy
Radiotherapy
Chemotherapy
Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Urothelial Carcinoma Treatment Revenue
1.4 Market by Type
1.4.1 Global Urothelial Carcinoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunotherapy
1.4.3 Radiotherapy
1.4.4 Chemotherapy
1.5 Market by Application
1.5.1 Global Urothelial Carcinoma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Urothelial Carcinoma Treatment Market Perspective (2015-2026)
2.2 Global Urothelial Carcinoma Treatment Growth Trends by Regions
2.2.1 Urothelial Carcinoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Urothelial Carcinoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Urothelial Carcinoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Urothelial Carcinoma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Urothelial Carcinoma Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Urothelial Carcinoma Treatment Players by Market Size
3.1.1 Global Top Urothelial Carcinoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Urothelial Carcinoma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Urothelial Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Urothelial Carcinoma Treatment Market Concentration Ratio
3.2.1 Global Urothelial Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Urothelial Carcinoma Treatment Revenue in 2019
3.3 Urothelial Carcinoma Treatment Key Players Head office and Area Served
3.4 Key Players Urothelial Carcinoma Treatment Product Solution and Service
3.5 Date of Enter into Urothelial Carcinoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Urothelial Carcinoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Urothelial Carcinoma Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Urothelial Carcinoma Treatment Market Size by Application (2015-2020)
5.2 Global Urothelial Carcinoma Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Urothelial Carcinoma Treatment Market Size (2015-2020)
6.2 Urothelial Carcinoma Treatment Key Players in North America (2019-2020)
6.3 North America Urothelial Carcinoma Treatment Market Size by Type (2015-2020)
6.4 North America Urothelial Carcinoma Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Urothelial Carcinoma Treatment Market Size (2015-2020)
7.2 Urothelial Carcinoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Urothelial Carcinoma Treatment Market Size by Type (2015-2020)
7.4 Europe Urothelial Carcinoma Treatment Market Size by Application (2015-2020)

8 China
8.1 China Urothelial Carcinoma Treatment Market Size (2015-2020)
8.2 Urothelial Carcinoma Treatment Key Players in China (2019-2020)
8.3 China Urothelial Carcinoma Treatment Market Size by Type (2015-2020)
8.4 China Urothelial Carcinoma Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Urothelial Carcinoma Treatment Market Size (2015-2020)
9.2 Urothelial Carcinoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Urothelial Carcinoma Treatment Market Size by Type (2015-2020)
9.4 Japan Urothelial Carcinoma Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Urothelial Carcinoma Treatment Market Size (2015-2020)
10.2 Urothelial Carcinoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Urothelial Carcinoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Urothelial Carcinoma Treatment Market Size by Application (2015-2020)

11 India
11.1 India Urothelial Carcinoma Treatment Market Size (2015-2020)
11.2 Urothelial Carcinoma Treatment Key Players in India (2019-2020)
11.3 India Urothelial Carcinoma Treatment Market Size by Type (2015-2020)
11.4 India Urothelial Carcinoma Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Urothelial Carcinoma Treatment Market Size (2015-2020)
12.2 Urothelial Carcinoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Urothelial Carcinoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Urothelial Carcinoma Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview
13.1.3 GlaxoSmithKline Urothelial Carcinoma Treatment Introduction
13.1.4 GlaxoSmithKline Revenue in Urothelial Carcinoma Treatment Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Urothelial Carcinoma Treatment Introduction
13.2.4 Novartis Revenue in Urothelial Carcinoma Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Urothelial Carcinoma Treatment Introduction
13.3.4 Merck Revenue in Urothelial Carcinoma Treatment Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview
13.4.3 Sanofi Urothelial Carcinoma Treatment Introduction
13.4.4 Sanofi Revenue in Urothelial Carcinoma Treatment Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview
13.5.3 Bristol-Myers Squibb Urothelial Carcinoma Treatment Introduction
13.5.4 Bristol-Myers Squibb Revenue in Urothelial Carcinoma Treatment Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 Genentech
13.6.1 Genentech Company Details
13.6.2 Genentech Business Overview
13.6.3 Genentech Urothelial Carcinoma Treatment Introduction
13.6.4 Genentech Revenue in Urothelial Carcinoma Treatment Business (2015-2020)
13.6.5 Genentech Recent Development
13.7 Eisai
13.7.1 Eisai Company Details
13.7.2 Eisai Business Overview
13.7.3 Eisai Urothelial Carcinoma Treatment Introduction
13.7.4 Eisai Revenue in Urothelial Carcinoma Treatment Business (2015-2020)
13.7.5 Eisai Recent Development
13.8 Dendreon
13.8.1 Dendreon Company Details
13.8.2 Dendreon Business Overview
13.8.3 Dendreon Urothelial Carcinoma Treatment Introduction
13.8.4 Dendreon Revenue in Urothelial Carcinoma Treatment Business (2015-2020)
13.8.5 Dendreon Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Urothelial Carcinoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Urothelial Carcinoma Treatment Revenue
Table 3. Ranking of Global Top Urothelial Carcinoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Urothelial Carcinoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Radiotherapy
Table 7. Key Players of Chemotherapy
Table 8. Global Urothelial Carcinoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Urothelial Carcinoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Urothelial Carcinoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Urothelial Carcinoma Treatment Market Share by Regions (2015-2020)
Table 12. Global Urothelial Carcinoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Urothelial Carcinoma Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Urothelial Carcinoma Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Urothelial Carcinoma Treatment Players
Table 19. Global Urothelial Carcinoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Urothelial Carcinoma Treatment Market Share by Players (2015-2020)
Table 21. Global Top Urothelial Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urothelial Carcinoma Treatment as of 2019)
Table 22. Global Urothelial Carcinoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Urothelial Carcinoma Treatment Product Solution and Service
Table 25. Date of Enter into Urothelial Carcinoma Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Urothelial Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Urothelial Carcinoma Treatment Market Size Share by Type (2015-2020)
Table 29. Global Urothelial Carcinoma Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Urothelial Carcinoma Treatment Market Size Share by Application (2015-2020)
Table 31. Global Urothelial Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Urothelial Carcinoma Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Urothelial Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Urothelial Carcinoma Treatment Market Share (2019-2020)
Table 35. North America Urothelial Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Urothelial Carcinoma Treatment Market Share by Type (2015-2020)
Table 37. North America Urothelial Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Urothelial Carcinoma Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Urothelial Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Urothelial Carcinoma Treatment Market Share (2019-2020)
Table 41. Europe Urothelial Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Urothelial Carcinoma Treatment Market Share by Type (2015-2020)
Table 43. Europe Urothelial Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Urothelial Carcinoma Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Urothelial Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Urothelial Carcinoma Treatment Market Share (2019-2020)
Table 47. China Urothelial Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Urothelial Carcinoma Treatment Market Share by Type (2015-2020)
Table 49. China Urothelial Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Urothelial Carcinoma Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Urothelial Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Urothelial Carcinoma Treatment Market Share (2019-2020)
Table 53. Japan Urothelial Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Urothelial Carcinoma Treatment Market Share by Type (2015-2020)
Table 55. Japan Urothelial Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Urothelial Carcinoma Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Urothelial Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Urothelial Carcinoma Treatment Market Share (2019-2020)
Table 59. Southeast Asia Urothelial Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Urothelial Carcinoma Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Urothelial Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Urothelial Carcinoma Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Urothelial Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Urothelial Carcinoma Treatment Market Share (2019-2020)
Table 65. India Urothelial Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Urothelial Carcinoma Treatment Market Share by Type (2015-2020)
Table 67. India Urothelial Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Urothelial Carcinoma Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Urothelial Carcinoma Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Urothelial Carcinoma Treatment Market Share (2019-2020)
Table 71. Central & South America Urothelial Carcinoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Urothelial Carcinoma Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Urothelial Carcinoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Urothelial Carcinoma Treatment Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Revenue in Urothelial Carcinoma Treatment Business (2015-2020) (Million US$)
Table 79. GlaxoSmithKline Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Product
Table 83. Novartis Revenue in Urothelial Carcinoma Treatment Business (2015-2020) (Million US$)
Table 84. Novartis Recent Development
Table 85. Merck Company Details
Table 86. Merck Business Overview
Table 87. Merck Product
Table 88. Merck Revenue in Urothelial Carcinoma Treatment Business (2015-2020) (Million US$)
Table 89. Merck Recent Development
Table 90. Sanofi Company Details
Table 91. Sanofi Business Overview
Table 92. Sanofi Product
Table 93. Sanofi Revenue in Urothelial Carcinoma Treatment Business (2015-2020) (Million US$)
Table 94. Sanofi Recent Development
Table 95. Bristol-Myers Squibb Company Details
Table 96. Bristol-Myers Squibb Business Overview
Table 97. Bristol-Myers Squibb Product
Table 98. Bristol-Myers Squibb Revenue in Urothelial Carcinoma Treatment Business (2015-2020) (Million US$)
Table 99. Bristol-Myers Squibb Recent Development
Table 100. Genentech Company Details
Table 101. Genentech Business Overview
Table 102. Genentech Product
Table 103. Genentech Revenue in Urothelial Carcinoma Treatment Business (2015-2020) (Million US$)
Table 104. Genentech Recent Development
Table 105. Eisai Company Details
Table 106. Eisai Business Overview
Table 107. Eisai Product
Table 108. Eisai Revenue in Urothelial Carcinoma Treatment Business (2015-2020) (Million US$)
Table 109. Eisai Recent Development
Table 110. Dendreon Business Overview
Table 111. Dendreon Product
Table 112. Dendreon Company Details
Table 113. Dendreon Revenue in Urothelial Carcinoma Treatment Business (2015-2020) (Million US$)
Table 114. Dendreon Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urothelial Carcinoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Immunotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Global Urothelial Carcinoma Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Urothelial Carcinoma Treatment Report Years Considered
Figure 10. Global Urothelial Carcinoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Urothelial Carcinoma Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Urothelial Carcinoma Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Urothelial Carcinoma Treatment Market Share by Players in 2019
Figure 15. Global Top Urothelial Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urothelial Carcinoma Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Urothelial Carcinoma Treatment Revenue in 2019
Figure 17. North America Urothelial Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Urothelial Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Urothelial Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Urothelial Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Urothelial Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Urothelial Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Urothelial Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介

尿路上皮がん診断の世界市場（～2026年）

Global Urothelial Carcinoma Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY04955 2020年11月20日 97Pages
当調査資料は尿路上皮がん診断のグローバル市場について調査・分析したレポートです。種類別（使用機器、試薬、キット）市場規模、用途別（委託研究機関、学術機関、病院、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

副腎皮質がん治療の世界市場（～2026年）

Global Adrenocortical Carcinoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13578 2020年11月30日 92Pages
当調査資料は副腎皮質がん治療のグローバル市場について調査・分析したレポートです。種類別（限局性副腎皮質がん、転移性副腎皮質がん）市場規模、用途別（病院、外来手術センター、診療所、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

頭頸部扁平上皮がん (HNSCC)治療の世界市場（～2026年）

Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04717 2020年11月20日 128Pages
当調査資料は頭頸部扁平上皮がん (HNSCC)治療のグローバル市場について調査・分析したレポートです。種類別（唾液腺、口腔および中咽頭、鼻腔および副鼻腔、鼻咽頭、喉頭および下咽頭）市場規模、用途別（病院、専門クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラ...

胸腺癌治療の世界市場（～2026年）

Global Thymic Carcinoma Treatment Market Insights and Forecast to 2026
MRC2-11QY10671 2020年11月25日 118Pages
当調査資料は胸腺癌治療のグローバル市場について調査・分析したレポートです。種類別（ベリノスタット、パシレオチドER、ミルシクリブ、TLC-388、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

結腸・直腸がんの世界市場（～2026年）

Global Colon & Rectal Carcinoma Market Size, Status and Forecast 2020-2026
MRC2-11QY11432 2020年11月25日 94Pages
当調査資料は結腸・直腸がんのグローバル市場について調査・分析したレポートです。種類別（大腸がん治療、直腸がん治療）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾...

基底細胞がん（BCC）治療薬の世界市場（～2026年）

Global Basal Cell Carcinoma Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11023 2020年11月25日 91Pages
当調査資料は基底細胞がん（BCC）治療薬のグローバル市場について調査・分析したレポートです。種類別（手術、放射線療法、光線力学療法、薬物）市場規模、用途別（小売薬局、病院薬局、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

神経内分泌がんの世界市場（～2026年）

Global Neuroendocrine Carcinoma Market Size, Status and Forecast 2020-2026
MRC2-11QY03951 2020年11月20日 96Pages
当調査資料は神経内分泌がんのグローバル市場について調査・分析したレポートです。種類別（化学療法、ソマトスタチン類似体、標的療法）市場規模、用途別（病院、診療所、腫瘍学センター、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

神経内分泌がん治療薬の世界市場（～2026年）

Global Neuroendocrine Carcinoma Drugs Market Insights and Forecast to 2026
MRC2-11QY08111 2020年11月20日 117Pages
当調査資料は神経内分泌がん治療薬のグローバル市場について調査・分析したレポートです。種類別（ソマトスタチン類似体、標的療法、化学療法）市場規模、用途別（病院、診療所、腫瘍学センター、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

高度腎細胞癌治療薬の世界市場（～2026年）

Global Advanced Renal Cell Carcinoma Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY13590 2020年11月30日 125Pages
当調査資料は高度腎細胞癌治療薬のグローバル市場について調査・分析したレポートです。種類別（放射線療法、化学療法、ホルモン療法、治験療法）市場規模、用途別（病院、がん研究所、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

腎細胞がん治療薬の世界市場（～2026年）

Global Renal Cell Carcinoma Drugs Market Insights and Forecast to 2026
MRC2-11QY09053 2020年11月25日 110Pages
当調査資料は腎細胞がん治療薬のグローバル市場について調査・分析したレポートです。種類別（ソマトスタチン類似体、標的療法、化学療法）市場規模、用途別（病院、クリニック、腫瘍学センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

尿路上皮がん診断の世界市場（～2026年） Urothelial Carcinoma or Transitional Cell Carcinoma encompasses cancer in different parts of urinary tract like kidney, bladder, ureters, and renal pelvis. The increasing trends of cigarette smoking is increasing the chances of urothelial carcinoma manifold. Market Analysis and Insights: Global Urot…
副腎皮質がん治療の世界市場（～2026年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…
頭頸部扁平上皮がん (HNSCC)治療の世界市場（～2026年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…
胸腺癌治療の世界市場（～2026年） Market Analysis and Insights: Global Thymic Carcinoma Treatment Market The global Thymic Carcinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Thymic Carcinoma Treatment Scope and Market Size Thymic Carci…
結腸・直腸がんの世界市場（～2026年） Market Analysis and Insights: Global Colon & Rectal Carcinoma Market The global Colon & Rectal Carcinoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Colon & Rectal Carcinoma Scope and Market Size Colon & Rectal Car…